{"name":"Nanoscope Therapeutics Inc.","slug":"nanoscope-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Gene Therapy-vMCO-010","genericName":"Gene Therapy-vMCO-010","slug":"gene-therapy-vmco-010","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Gene Therapy-vMCO-010","genericName":"Gene Therapy-vMCO-010","slug":"gene-therapy-vmco-010","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxNWjFfTlBlTkFjWnRnTnpTbC1VZnp0Y2ZCaFB0dkZMYjBpOHZreXZidzNkWlZPV2xyVk12QjhyZVlBalprMGkxUWNoYk53NEktTXIxNnVjVmxIcFgyOTU5ZmgxT0F2XzI2TUtONFlFWGMyYWVQNTZEUkZQZUdLbEFCRWgwcS14SGg5ZWh6SWxZYlFLdWhkX1FIMlhHY0VWZTlHb1UxOHlFelBqZFpSb2hjVllQY254WXRKRjk1M1NkMVVBVTduWlRoMkxkbUlMY3V2bXZacWNXTnFMN2ZrX044ZjlEUGdsSm9aM0F1azZERkNBN0pnLUxSOGZGVFpkSmVpNFFmRg?oc=5","date":"2026-03-23","type":"trial","source":"PR Newswire","summary":"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease - PR Newswire","headline":"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPQkR4OFBzVmRkZ1BnZmhnbEFYd2NmNXpDQjVGODJOWW9pQWQydFBmMUxpRVFlelNCZ1ZhT1FiTHJWSnZxNUdnaFMwT0luVFlwVnFCc0x0NDJ4bUxjZU53SktOY0p3anlNYnppdHJpMmlQeWhZVWlHa2FuZ1NBNzBxLXYyeThBVS1vOGVNOFpNVkFmQ1FSMWFlZE5fSzdlX1R2Q29kUGYzWEZrQy0wbnBHbU02QTFFMklBaEZrMnBmcG1oVzBFR25FcnRMX2RnVzlNc0tsVU41LVlFaVhuQ1VUT3lNZ1Jtc2VxWGhXN1I0ejg?oc=5","date":"2026-02-24","type":"pipeline","source":"PR Newswire","summary":"Nanoscope Therapeutics Post-Hoc Clinical Analyses to be Presented at 2026 Macula Society Annual Meeting - PR Newswire","headline":"Nanoscope Therapeutics Post-Hoc Clinical Analyses to be Presented at 2026 Macula Society Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxNcExXbDRXdE1YUnpjU1pBS0UxeTdfb25MRWRWTjF5Q2ZkVGZqZ0hUckt4cmt5clVQaUZpVHQ5dnBYMzl0SDRfTEItdTZyc0lLVlA0VzdlZ2Eyc0ZOVHVqd0dETjNyaVNobkJBbGZldnhCYUE2R3VLS1ZyRWZMUUxHdjBMbTJTYzl2aFdBVXkwdjZrclVFMW55cU84SExpMEpLUm9wNHhWcHVUcjBMZEs1cXFJWXprYm9nV0pnbkJyVGlLc3ZFc2tmQW9RbndjRC1RY1VXaEZPUHBYMnUwWnhkd213ZWlOaHJRM3llY1BKOFlDSUQ1WjdFWTNKcGhoTlFxWnlsV3FtRlFSazlsS29palVfWWp2TDNNOENaR09YelpKMDVCbnR3M3VON1dNVmt3RkI0eVJ6U21wRE0xUzhrWFk4b3VpUFlMdjJOQ1BMbEFrREE?oc=5","date":"2026-01-23","type":"regulatory","source":"Barchart.com","summary":"Stargardt Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Nanoscope Therapeutics, Belite Bio, Biophytis, reVision Therapeutics - B","headline":"Stargardt Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveIn","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNWC1qdXNPOXpZbm9SeldDUmlNYkx5WkZVbTg1N1lXZWw1LU1aZ3BHTkhOSm5sT1NRcHQxa0tSX19tZXI5X284RDRjN1BnaXRsenQtQ1p1T2hudzFHSi1oUnFpcnREN3ZUODhFcnFjbHkxbFBRZlRTendCNXdZTXd5T09ZdkxxMlZxMkFfdVlWZlpnT1MxUkZ3U3Vlb1hOaVN4eFZVZ3FudHlybGU4TGJnUDNHdmN1b0Y0VF8wSWJiQ2tWbkFHd2p5MUtzVU1WdWk1US1MMkhvVVZwSjF1LVBvX3FoNlc5OGxHWDlDQzFNMVlUWkktWVVCcGNJMVdZaUxROTl3NkF0NFZieW5mTUVUZnRR?oc=5","date":"2026-01-07","type":"patent","source":"PR Newswire","summary":"Nanoscope Therapeutics Granted New U.S. Patent Covering Its Proprietary Multi-Characteristic Opsin Platform for Vision Restoration - PR Newswire","headline":"Nanoscope Therapeutics Granted New U.S. Patent Covering Its Proprietary Multi-Characteristic Opsin Platform for Vision R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNMUJ1MVB1V0NPM0Q1NlFHSFlmQk01Nmt3Y0p2dUFUOGJYY3lCaXI1QUg5a3hxbXFXTzRaUDFEWVNkcHQyNGdPa2VTQy1jSUgzUHpJQTQ1c0VKQS1EeXZ1bkxNa2VyZWZuTURWbVdSTnVqZkFJcHdma21KZU40VWhHc0dxM3NreTRQb0NhdnhWQ1MzdEM2YUM5LU5HZTJnWEF0VXNybkFvTktpek1FRDlRS2tMZHY3ZnB0a2pqZHNpb2hTTm9QbW1UdGZ5TGg0SWZJU2E2UW95RE5yNzVRelNfaWZiUUd2clJRaXVv?oc=5","date":"2025-12-02","type":"trial","source":"Citeline News & Insights","summary":"Belite Bio’s Tinlarebant Shines In Phase III Stargardt Disease Trial - Citeline News & Insights","headline":"Belite Bio’s Tinlarebant Shines In Phase III Stargardt Disease Trial - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNd0hfbGttSDl1LVJyMV9NeTNmNjlwVFZ3cm5YRjN4eUwwMXhqZnNXNHV2Qml6YlRVbWh0VkpsV0pJSlNwQ2hIaUlGSnVzaWlhT2Z5eTZ1Rml4NF9XYzUyYXhlNDZQT2hrQ25JLW5vVU1xMnRQMUhSVUpYTno3eVVVZ2dqd25SM2hCbzFER0paT2FOV1RGZS1XRWxzcDdoQm5GeFdXY0xCMkgzRG1MYTJHend2R2VrV0lFcDhMbnZxbF9pQ09ha3lzZW9pOVFsQnNrWUJvcWRTdnVYQ3Ri?oc=5","date":"2025-11-17","type":"pipeline","source":"PR Newswire","summary":"Nanoscope Therapeutics Featured in Multiple Presentations at Advanced Therapies USA 2025 - PR Newswire","headline":"Nanoscope Therapeutics Featured in Multiple Presentations at Advanced Therapies USA 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxOSFlrYjVxUnJXZW9EaEJKUXBjWHJCcmlZQlJWNEZ5WHZVQklSclBNU3ZyYjk1c2ZmODhZazVWWHRMekk0V1I2a3duS3Qtc1kwMHd6RTltNWctbGFOdlZla29HeUJsZWpZaDg1a1I2NFhUemNQMG43U0NwSlU5UzlJb1RzdmNhNVNWNWNYMzNvc3RpQUw5MXZGZzZnRV9uS1ZHcHF1REdMSU9UbmF4VmI2VWlzdEgzd3JRWmo1dllkWV9GcFkxZ1lEcjc5YkNkeEdsWFZWNGRxRVByRmhOdkVQUF95dVZiMHAyTkFzTmU4a0h3bmxtTjJnMi10SGdCWlFZSklzRUUwaw?oc=5","date":"2025-10-22","type":"regulatory","source":"PR Newswire","summary":"Nanoscope Therapeutics Announces Durable 3-Year Vision Improvements from REMAIN Study of MCO-010 in Retinitis Pigmentosa - PR Newswire","headline":"Nanoscope Therapeutics Announces Durable 3-Year Vision Improvements from REMAIN Study of MCO-010 in Retinitis Pigmentosa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOXzJNRXBMZkJzeTNYLWtIeVpIQWpVRFVBTWhiVTV0MjhvVWZONjlwbVdicmk2NmhsNDVhT2pKREZacmtXd2VYSU13bDh0X2ttMWhfeUc1TlFsb1lfZUtjeXZqTl8tU2YtaHY1T0V0d1VqalBJMEJyMkpMWUx1N3FtZklRTkNibHRLQ1F1V1VOdjBsMlhHMThEaENjUDh4QV95VTlvZGR4MXRZaWFGUW94ZnQxNGJ2Q2g4QUZnSDk1NU9wSU1DUWYzemtWenU2ZUlEOXM5YUwxbEJBck01T0h2VW5mSm9TcHFZQTJtODdNOW9FUk81VFJES295aU4ybDU5RWc?oc=5","date":"2025-10-13","type":"pipeline","source":"PR Newswire","summary":"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting - PR Newswire","headline":"Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxQWFdYR2g5NXp3NVRiWGlXWnJPS3NHZVRCejR0UGRFLWhGQjZad3U0ZEVNS3hpRFN0OHVfSVl3QmU2ODZFbE0yQmdJNlRFZlNzblJRYjJtTzBOZEdaQkFWSWRPVGUyOS1QN3VYdDNzMGVuMll1UVdWaXpDTHhMa0FndG1ueWZFUGs4Q3VhTjVfZmtBOHUybHY0UTcyaWVKRUJOdU5scEJ4RFl2Nmk5UHB5bGxITFBSdUttSFIzeXNleDNyQnVWRjFTX2lBNzZMdGFXZXItWERhRmg4U092OFpDVmFSV3d5UWhyOS1OTDVTRGFONVlSNGZNY01rVmZtUlJtaVdtZW9XWXc4Q0d3YVVJZ0NkSldmUEFGX0xmWkEyU00yUE9RenN6bk1qMDhTZWhGZWcyR2hTRUIzb09qRnloNUFUOA?oc=5","date":"2025-07-14","type":"regulatory","source":"PR Newswire","summary":"Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa - PR Newswire","headline":"Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNR3NmM1NMaWZUY3gyLWdNVldPTFRuRXBfT3dvSnowcXp3MUxqMGs0Um5KVV9RMEMwUEc5TmlMRFFodzhjQVY5aGZ2anNjMmg0WW15R2lUbkFKVUJDekdfMnpJODNIQlpabDl4QVBRaGpsOHd2aGtsN0ZRVC16dXN1N25ENmJBSU1RMnlNTzl3TTlBQUVmTmthNktERnhjeDN1dU44QVVsVzYwNWMzTVE?oc=5","date":"2025-04-30","type":"pipeline","source":"Ophthalmology Times","summary":"Companies announce presentations at upcoming 2025 ARVO Annual Meeting - Ophthalmology Times","headline":"Companies announce presentations at upcoming 2025 ARVO Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNejBHWG1LTV9IYXFzQ19oVklwVFZacmVPbGhBQzREekk5NENybU1qUnBtYUVkNS1JSk51UTJuV0lrTmNHOVc4V2lsWG9oUmdYc0xtX21rU3dpWWJiX0R2NFhTaUktRmhzd2VWb1psRkh5Vl8yeWhFdE5VTkZtelpZX1JUSmNlczl3OGRIdFNxV3M4emVBNlQtWWJFUHF0OUpDZ3FpYWFCR1AwMk5Cd25aekprb2UxMEgwaUxHUHNfWkxJVW1BOHFMQS1GRmpLUjNPUzhkdFZ0RVlURjdoUjRkSTN5cTdaMVVjU2toczA5NndVVGpxY1g1WEpUTHQ?oc=5","date":"2025-03-27","type":"pipeline","source":"PR Newswire","summary":"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing - PR Newswire","headline":"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNR3QtTjRUNTloXzJITU4xanZMS2NJbzN3R1NRaUl4SnRHcVZHYU9XbGJwRWVRam1xRzU2QUFpR2Y2LVNOejFfWDFaWGlJc3hoT1JxM01uOXFybmh6VGpobVl2MUxodERfWXZVd0JKbGcxMWxWbDdMTEpKM2M3cW1IOUlfbXJmcExTUHZ4QldLSmx3aTJfeXJZWk1wRFFLUWZDZTNFQ2xzdVJzalF5QzBTR3cwMExHc3ZiTkJERkx5allIazZDeW1INg?oc=5","date":"2024-05-19","type":"pipeline","source":"2 Minute Medicine","summary":"Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosa - 2 Minute Medicine","headline":"Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosa - 2 Minute Medicine","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}